An optimized GC–MS method detects nanomolar amounts of anandamide in mouse brain
- 1 February 2008
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 373 (2) , 220-228
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Quantification of endocannabinoids in rat biological samples by GC/MS: Technical and theoretical considerationsProstaglandins & Other Lipid Mediators, 2006
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006
- Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotectionProceedings of the National Academy of Sciences, 2006
- Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agentsCell Metabolism, 2006
- Fatty acid amidohydrolase in human neocortex—activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoidsNeuroscience Letters, 2005
- The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activityJournal of Lipid Research, 2005
- Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cellsBiochemical Journal, 2002
- Endocannabinoids control spasticity in a multiple sclerosis modelThe FASEB Journal, 2000
- Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological FunctionBiochemical and Biophysical Research Communications, 1999
- Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brainFEBS Letters, 1995